FOLFIRINOX in Locally Advanced and Metastatic Pancreatic Cancer: A Single Centre Cohort Study

Introduction: FOLFIRINOX is emerging as new standard of care for fit patients with locally advanced pancreatic cancer (LAPC) and metastatic pancreatic cancer (MPC). However, some of the physicians are reluctant to use FOLFIRINOX due to high toxicity rates reported in earlier studies. We reviewed our...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Cancer
Asıl Yazarlar: Rombouts, SJ, Mungroop, TH, Heilmann, MN, van Laarhoven, HW, Busch, OR, Molenaar, IQ, Besselink, MG, Wilmink, JW
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Ivyspring International Publisher 2016
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5039370/
https://ncbi.nlm.nih.gov/pubmed/27698926
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.16279
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller